Long-term effects of postnatal amphetamine treatment on striatal protein kinase A activity, dopamine D(1)-like and D(2)-like binding sites, and dopamine content.
The purpose of the present study was to determine whether exposure to amphetamine during the preweanling period would alter dopaminergic functioning in the dorsal striatum of adult rats. In three experiments, we assessed the effects of repeated amphetamine treatment on striatal protein kinase A (PKA) activity, dopamine (DA) D(1)-like and D(2)-like binding sites, and DA content. Rats were pretreated with saline or amphetamine (2.5 mg/kg, ip) for 7 consecutive days starting on postnatal day (PD) 11. At PD 90, rats were killed and their dorsal striata (i.e., caudate-putamen) were removed and frozen until time of assay. Amphetamine pretreatment produced long-term reductions in both striatal PKA activity and DA content. Early amphetamine exposure also resulted in an upregulation of D(2)-like binding sites, while leaving D(1)-like binding sites unaffected. It is likely that the upregulation of D(2)-like binding sites was stimulated by the persistent decline in striatal DA levels. Although speculative, it is possible that excess striatal D(2)-like receptors were responsible for inhibiting PKA activity through actions on the cAMP signal transduction pathway. The behavioral relevance of these amphetamine-induced neurochemical changes has not yet be determined.
Crawford
C A
CA
Department of Psychology, California State University, 5500 University Parkway, San Bernardino, CA 92407-2397, USA. ccrawfor@csusb.edu
Zavala
A R
AR
Karper
P E
PE
McDougall
S A
SA
D000661:Amphetamine / Q000494:pharmacology*; D000818:Animals; D000831:Animals, Newborn; D001665:Binding Sites / Q000187:drug effects; D001667:Binding, Competitive; D001835:Body Weight / Q000187:drug effects; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects* / Q000378:metabolism; D017868:Cyclic AMP-Dependent Protein Kinases / Q000187:drug effects* / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D005260:Female; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D017207:Rats, Sprague-Dawley; D017448:Receptors, Dopamine D2 / Q000378:metabolism; D012965:Sodium Chloride / Q000494:pharmacology; D013997:Time Factors
D000697:Central Nervous System Stimulants; D017448:Receptors, Dopamine D2; D012965:Sodium Chloride; D000661:Amphetamine; D017868:Cyclic AMP-Dependent Protein Kinases; D004298:Dopamine